CM Management’s Exelixis EXEL Stock Holding History

CM Management’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-80,000	Closed	-$1.81M	–	89
2021 Q1	$1.81M	Buy	+80,000	New	+$1.81M	1.34%	21

Other funds holding EXEL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

CM Management's EXEL Position: Q2 2021 in Review

CM Management sold out of Exelixis (EXEL) in Q2 2021, closing a stake of 80,000 shares — an estimated $1.81M sold.

CM Management first reported a position in EXEL in Q1 2021 and held it in 1 quarter. The position peaked at $1.81M in Q1 2021. 345 funds tracked by Wall St. Rank hold EXEL as of Q2 2021.

CM Management reported no remaining Exelixis position as of Q2 2021 after selling out during the quarter.
CM Management sold 80,000 Exelixis shares in Q2 2021, an estimated $1.81M.
CM Management first reported a position in Exelixis in Q1 2021 and held it in 1 quarter.
CM Management's Exelixis position peaked at $1.81M in Q1 2021.
345 funds tracked by Wall St. Rank held Exelixis as of Q2 2021.

Based on CM Management's 13F filing for Q2 2021, filed 10 Aug 2021.